Podcasts about cme

 This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one.____________What if the search for your “one true purpose” is actually making you miserable and the real path to a regret-free life is simpler than you think?In this insightful conversation, Dr. Bradley Block reconnects with returning guest Dr. Jordan Grumet to explore the ideas in his new book, The Purpose Code. Building on his first book Taking Stock, Jordan tackles the question he's asked most: “How do I actually find purpose?” He breaks down why we get purpose wrong, introduces Big P vs. little p purpose, and shares why focusing on process over outcome creates abundance, community, and lasting happiness. From hospice stories to personal examples like podcasting and baseball cards, Jordan shows physicians how to build purpose around what truly fills them up, without needing to quit medicine or chase scarcity-driven goals.If you've ever felt purpose anxiety or wondered whether being a doctor is “enough,” this episode offers a practical, liberating framework to live intentionally and regret-free.Three Actionable Takeaways:Distinguish Big P from little p purpose: Stop chasing scarce, audacious goals (e.g., curing cancer, becoming a billionaire) that breed anxiety and failure. Instead, identify activities where you love the process itself regardless of outcome or pay. Ask: “Would I do this even if no one paid me or noticed?” These abundant little p purposes bring joy, flow, and surprisingly greater impact.Build purpose now, not after financial milestones: Don't wait for financial independence to pursue what lights you up. Use the 5–6 hours of daily free time most people have to fill time slots with purposeful activities. At work, maximize what you enjoy (addition), minimize what you loathe (subtraction), or switch roles or employers to increase joy without blowing up your finances.Pair purpose with meaning for true happiness: Purpose (present/future actions that fill you up) needs meaning, a heroic narrative of your past, to thrive. Reframe past struggles as a hero's journey “I am enough” to quiet victim stories that sabotage new purposeful pursuits. Strong relationships and community naturally flow from living your little p purpose, which research shows is the biggest predictor of health and longevity.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest:Dr. Jordan Grumet, known as Doc G, is an associate medical director at Unity Hospice, a Plutus award-winning podcaster for Earn & Invest, and a prominent voice in the Financial Independence, Retire Early (FIRE) community. With a background in internal medicine and a shift to hospice care, he authored Taking Stock: A Hospice Doctor's Advice on Financial Independence, Building Wealth, and Living a Regret-Free Life, which reshaped how people align money with values. His second book, The Purpose Code (releasing January 7, 2025), explores creating purpose through process rather than goals, drawing from his hospice insights and personal journey to inspire a fulfilling life.LinkedIn: http://linkedin.com/in/jordan-grumet-38a506179 Website: https://jordangrumet.com/ Podcast: https://podcasts.apple.com/ng/podcast/earn-invest/id1440355498About the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Featuring perspectives from Dr Lisa A Carey and Dr Rita Nanda, including the following topics:  Overview: Molecular basis of antibody-drug conjugate (ADC) toxicities — Sequencing of ADCs and mechanisms of resistance (0:00) Case: A woman in her late 60s with localized triple-negative breast cancer develops myocarditis during neoadjuvant therapy with chemotherapy/pembrolizumab — Richard Zelkowitz, MD (8:22) Case: A woman in her mid 70s with recurrent ER-negative, HER2-low, PD-L1-positive metastatic breast cancer (mBC) who experiences disease progression on nab paclitaxel/atezolizumab responds to sacituzumab govitecan — Ranju Gupta, MD (26:43) Case: A woman in her early 80s with recurrent ER-positive, HER2-low (IHC 1+) mBC experiences disease progression on trastuzumab deruxtecan (T-DXd), then receives datopotamab deruxtecan and develops pulmonary symptoms — Laila Agrawal, MD (32:11) Data Review: T-DXd (37:51) Case: A woman in her early 70s with recurrent ER-positive, HER2-low (IHC 1+) mBC, including bladder metastases, experiences disease progression after palbociclib/letrozole, then capivasertib/fulvestrant, then nab paclitaxel — Justin Favaro, MD, PhD (44:02) Case: A woman in her late 70s with ER-positive, HER2-low mBC who experiences disease progression after 1 year of ribociclib/letrozole receives sacituzumab govitecan — Erik Rupard, MD (55:19) CME information and select publications

Send us a textImagine this: You see a patient, perform the exam, document the care, your staff submits the claim—to all appearances everything looks right. But then the claim comes back denied. The team may shrug, file it away, mark it unresolved. And the revenue disappears. What you delivered—the service, the documentation, the provider expertise—is lost financially. And more often than you think, this is happening silently. And this is in addition to the money you're losing on adjustments, which we reviewed in our last episode.Today we're diving into an issue that's also quietly eroding the bottom line of many medical groups: claim denials that aren't followed up. The stats are startling: about 20% of medical insurance claims are denied (yes, you heard that correctly: one‑in‑five) and around 65% of those denials are never appealed or corrected. Put those together and you get this: if 20% are denied, and 65% of those are lost, you're effectively giving away 13% of your revenue. That's a huge hit—and yet most practices aren't managing it as one of their top financial risks. Many aren't even aware of it. They've just gotten used to it over the years as an “acceptable loss.”This isn't theory—it's real work you've done, for real patients, with real documentation and care. And if you don't follow up on denials, you're essentially saying someone else's rules are dictating your revenue. For physician groups, this means margin gets squeezed, growth stalls, and independence becomes harder to maintain. All because you're handing over a bunch of money to the payers.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Find it here: https://healtheps.com/physicians-edge-mastering-buPurchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

Dr Lisa A Carey from the UNC Lineberger Comprehensive Cancer Center in Chapel Hill, North Carolina, and Dr Rita Nanda from The University of Chicago in Illinois engage in an evidence-based discussion around real-world cases involving common toxicities associated with antibody-drug conjugates in the management of breast cancer.CME information and select publications here.

With the end of 2025 upon us, we wanted to find some of the short stack conversations from the past year. So for this short stack, you'll here our 4 hosts, and frequent guests Matt Delaney and Christ Colbert join us for some random questions that will leave you laughing. Don't forget, we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more about an upcoming CME event!

Featuring perspectives from Dr Yelena Y Janjigian, including the following topics: Introduction (0:00) Case: A man in his early 60s with a history of Barrett's esophagus presents with HER2-positive metastatic esophageal adenocarcinoma and a PD-L1 combined positive score (CPS) of 3 — Jennifer Yannucci, MD (10:20) Case: A man in his early 60s with multiregimen-recurrent HER2-positive gastroesophageal junction (GEJ) adenocarcinoma (claudin 18.2-positive, PD-L1 CPS 0) — Neil Morganstein, MD (14:53) Case: A woman in her early 80s with dementia and newly diagnosed mismatch repair-deficient, PD-L1-positive metastatic GEJ adenocarcinoma — Brian P Mulherin, MD (25:55) Case: A man in his mid 60s with localized HER2-negative GEJ cancer (PD-L1 CPS 2, claudin 18.2-positive) and residual disease after receiving neoadjuvant chemoradiation therapy and undergoing surgery — Stephen "Fred" Divers, MD (32:18) Case: A man in his early 80s with metastatic recurrence of esophageal adenocarcinoma and a PD-L1 total proportion score of 75% 2 years after resection of localized disease — Susmitha Apuri, MD (40:28) Case: A man in his mid 70s with claudin 18.2-positive metastatic esophageal adenocarcinoma who develops progressive toxicities with FOLFOX and zolbetuximab — Sean Warsch, MD (52:54) CME information and select publications

Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.CME information and select publications here.

Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.CME information and select publications here.

Dr Yelena Janjigian from Memorial Sloan Kettering Cancer Center in New York, New York, discusses updates across the treatment landscape for gastroesophageal cancers, as well as real-world clinical case examples.CME information and select publications here.

I give my perspective on being an APP in the ED, be humble and teachable and strike an affect that allows the physicians to speak into your practiceWhen in doubt, consult the specialistJulie talks about what makes her proud about her careerShe is proud of the connections she made, that she treated her patients how she would have wanted to be treatedRemember to take that intentional time with patients to help reassure and connect with themJulie talks about a the expectation she sets for patients with abdominal pain -  that we don't find a clear answer most of the time and when we do it's usually something emergent and surgical so sometimes no answer is good newsSet the right expectation for the ER visit earlyShe talks about how she reassures patients that may be embarrassed for coming in when they end up not having anything emergent going onJulie highlights the need to eat and hydrate on shiftJulie talks about the next generation of providers and how she hopes they continue to keep their observation skills and clinical thinking skills intact considering technology advances and AI incorporation Julies advice to her younger self would be to not let people drag you downA big thing we need to learn is to not let others poor behavior or flexing of their ego affect us personally, it speaks more about them than usWe need to learn to give constructive criticism without judgingSupport the showEverything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions. This is not medical advice. If you have personal health concerns, please seek professional care. Full show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics: Introduction (0:00) Prostate Cancer (1:44) Urothelial Bladder Cancer (29:18) CME information and select publications

Dr Terence Friedlander from the UCSF Helen Diller Family Comprehensive Cancer Center and Dr Rana R McKay from the UC San Diego Moores Cancer Center summarize the treatment landscape for prostate and urothelial bladder cancer and discuss the implications of clinical findings recently presented at the ESMO Congress 2025.CME information and select publications here.

The holiday push is wrapping up, and the markets are starting to show their hand. Beef is splitting in two directions, poultry feels steady but uneasy, pork stays a value, grains won't budge, and dairy may finally be finding a floor. With January right around the corner, the next two weeks could set the tone for everything that follows.BEEF: Holiday pricing is making its final stand, and the beef market is starting to split in two directions. Middle meats are finally easing while other cuts quietly set up their next move. Two weeks from now, this market could look very different.POULTRY: Chicken finishes the year well supplied and steady, but this calm feels temporary. With avian flu still popping up and no real downside left, the next move is likely up – the only question is when.GRAINS: Soy export news finally surfaced, but the grain markets barely blinked. Corn, soy, and wheat remain stuck in neutral, waiting for something – anything – to break the stalemate.PORK: Bellies slide again, keeping bacon firmly in value territory heading into the new year. With strong production and solid inventories, pork remains one of the quiet winners on the board.DAIRY: Dairy prices are sending mixed signals, hinting the recent slide may be running out of steam. Whether this is the bottom or just another pause is the next story to watch.Savalfoods.com | Find us on Social Media: Instagram, Facebook, YouTube, Twitter, LinkedIn

In this podcast episode, Jeremy S. Abramson, MD, MMSc, reviews data from select presentations in lymphomas at the ASH 2025 Annual Meeting and provides perspectives on the clinical implications of these data for patients with chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL), including:CLL17: randomized phase III trial of continuous ibrutinib vs fixed-duration venetoclax plus obinutuzumab or venetoclax plus ibrutinib for untreatedCLL BRUIN CLL-313: randomized phase III trial of pirtobrutinib vs BR for previously untreated patients with CLLBRUIN CLL-314: pirtobrutinib vs ibrutinib in treatment-naive and BTKi-naive R/R CLL/SLL EPCORE-FL-1: randomized phase III trial of epcoritamab with rituximab and lenalidomide vs rituximab and lenalidomide for R/R FLSTARGLO: 3-year follow-up data from the randomized phase III trial of glofitamab plus GemOx vs rituximab plus GemOx for patients with R/R DLBCLPresenter: Jeremy S. Abramson, MD, MMScProfessor of MedicineHarvard Medical SchoolDirector, Center for LymphomaMass General Brigham Cancer InsBoston, MassachusettsContent based on an online CME program supported by educational grants from AstraZeneca, BeOne Medicines, Genentech, Geron Corporation, Incyte, Johnson & Johnson, Lilly, and Novartis Pharmaceuticals Corporation.Link to full program:https://bit.ly/4aqMobZ Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

“People are not looking for a perfect, polished answer. They're looking for a human to speak to them like a human,” says Jessica Malaty Rivera, an infectious disease epidemiologist and one of the most trusted science communicators in the U.S. to emerge from the COVID-19 pandemic. That philosophy explains her relatable, judgement-free approach to communications which aims to make science more human, more accessible and less institutional. In this wide-ranging Raise the Line discussion, host Lindsey Smith taps Rivera's expertise on how to elevate science understanding, build public trust, and equip people to recognize disinformation. She is also keen to help people understand the nuances of misinformation -- which she is careful to define – and the emotional drivers behind it in order to contain the “infodemics” that complicate battling epidemics and other public health threats. It's a thoughtful call to educate the general public about the science of information as well as the science behind medicine. Tune in for Rivera's take on the promise and peril of AI-generated content, why clinicians should see communication as part of their professional responsibility, and how to prepare children to navigate an increasingly complex information ecosystem.Mentioned in this episode:de Beaumont Foundation If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Welcome back to the Oncology Brothers podcast! In this episode, we continue the CME series on HER2-positive GEJ and gastric cancer, shifting focus to the essential topic of treatment toxicity management. We're joined by two leading experts: Dr. Geoffrey Ku from Memorial Sloan Kettering and Dr. Shruti Patel from Stanford University. Building on their previous discussion of upper GI treatment algorithm with Dr. Rutika Mehta, this episode delves into the practical realities of managing patients on complex regimens. Drs. Ku & Patel break down the side effect profiles across the treatment continuum—from frontline trastuzumab-based combinations to emerging therapies like zanidatamab—and provide actionable strategies for community oncologists. Episode Highlights: • Practical management of frontline side effects with FOLFOX/XELOX chemotherapy plus trastuzumab and pembrolizumab • Reality check on trastuzumab cardiotoxicity: incidence rates and monitoring protocols in gastric vs. breast cancer • Immune-related adverse events with checkpoint inhibitors: what's common vs. rare in GI cancers • Critical insights on zanidatamab's synergistic diarrhea toxicity and mandatory prophylaxis strategies • TDXd (Enhertu) in second-line: moving beyond ILD fears to address frequent cytopenias and marrow management • Expert consensus on infusion reaction management for novel biologics • The importance of managing baseline symptoms in patients with dysphagia and nausea This episode bridges the gap between trial data and clinical practice, offering real-world wisdom on keeping patients on effective therapies through proactive toxicity management. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for our complete CME series covering treatment algorithms, FDA approvals, and practical management strategies! Accreditation/Credit Designation Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc. Link to gain CME credits from this activity: https://www.gotoper.com/courses/navigating-the-adverse-event-landscape-in-her2-gea-therapy

Alex Mead from StoneX joins Gregg, Matt, Ashley, and Charles for a milestone Episode 150 packed with market insight. The group breaks down current lumber conditions, why the new CME SYP lumber contract is positioned to grow in the coming years, and what the Commitment of Traders Report is signaling about the next move. They discuss the wide spread between CME and spot lumber, how buyers across the supply chain are reacting, and whether being short into Q1 could be risky. Stick around to the end for early 2026 forecasts and a strong close from Matt, highlighting gratitude for the industry and why this market still matters. Advertisers: Fastmarkets Random Lengths djalbert@fastmarkets.com www.fastmarkets.com Layman's Lumber Guide www.laymansguide.com Matt@laymansguide.com Show Contacts: Gregg Riley: Gregg@sitkainc.com Charles DeLaTorre: cdelatorre@ifpwood.com Matt Beymer: mattbeymer@hamptonlumber.com Guest: Alex Mead Risk Management Consultant StoneX Alex.mead@stonex.com

Welcome to Perimenopause WTF!, brought to you by ⁠Perry⁠—the #1 perimenopause app and safe space for connection, support, and new friendships during the menopause transition. You're not crazy, and you're not alone!  Download the free Perry App on ⁠Apple⁠ or ⁠Android⁠ and join our live expert talks, receive evidence-based education, connect with other women, and simplify your perimenopause journey.Today's episode is titled “Myth vs Reality What You Should Know About Managing Perimenopause Symptoms Through Lifestyle” Ditch the "quick-fix" myths and get the facts on how lifestyle changes and exercise actually impact your perimenopause journey. Fitness experts Lauren Colenso-Semple and Amanda Thebe answer the Perry community questions and break down the science of strength training, nutrition, and stress management to help you build a sustainable toolkit and feel your best.

In this episode, Hanny Al-Samkari, MD, gives his thoughts on 5 key presentations from ASH 2025, and provides perspectives on the clinical implications of these data for patients with nonmalignant hematologic disorders such as ITP and vWD, including: LBA-2: Primary results from VAYHIT2, a randomized, double-blind, phase III trial of ianalumab plus eltrombopag vs placebo plus eltrombopag in patients with primary immune thrombocytopenia (ITP) who failed first-line corticosteroid treatmentAbstract 844: Secondary analysis results from VAYHIT3, a phase II study of ianalumab in patients with primary immune thrombocytopenia previously treated with at least 2 lines of therapyAbstract 5: Deciphering the dilemma: intravenous (IV) iron use in iron deficiency anemia during acute infectionsAbstract 308: Subcutaneous, every-4-week maintenance dosing of a novel protein S antibody is well tolerated and substantially reduces bleeding rates: results from a phase I/II multidose study of VGA039 in patients with von Willebrand diseaseAbstract 841: Immune thrombocytopenia in patients treated with immune checkpoint inhibitorsPresenter:Hanny Al-Samkari, MDThe Peggy S. Blitz Endowed Chair in Hematology/OncologyCo-Director, Hereditary Hemorrhagic Telangiectasia Center of ExcellenceMassachusetts General HospitalAssociate Professor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by educational grants from AstraZeneca, BeOne Medicines, Genentech, Geron Corporation, Incyte, Johnson & Johnson, Lilly, and Novartis Pharmaceuticals Corporation.Link to full program:https://bit.ly/48Ye45N Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Have you ever found yourself helping a loved one through a confusing medical situation and thought, "I wish I could do this full-time"? You're not alone. Many physicians are naturally drawn to patient advocacy and navigation, even if they don't yet realize it has a name or a career path. In this episode, I'm joined by Dr. Angie Ingraham, a former trauma surgeon and critical care physician who made a powerful career transition after her father's diagnosis with glioblastoma. Experiencing the healthcare system from the other side opened her eyes to the gaps patients and families face. That journey led her to launch True North Patient Advocates, where she now supports others through complex medical situations with clarity and compassion. Whether you've thought about becoming a patient advocate and navigator — or are simply curious about what this work actually involves — Angie shares the real-life steps she took to create a fulfilling and sustainable new path.   In this episode we're talking about: How a personal family crisis led Dr. Ingraham to explore patient navigation The surprising barriers patients face, even with medical connections What professional patient advocates and navigators actually do and how physicians are uniquely qualified How she built her business without formal business training The variety of clients and services in her day-to-day work Financial considerations and typical rates for advocates Steps you can take to explore this path for yourself You can find the show notes for this episode and more information by clicking here: www.doctorscrossing.com/episode236 Links for this episode: Dr. Angie Ingram — True North Patient Advocates Greater National Advocates Directory Alliance of Professional Health Advocates - Offers a Boot Camp and 100-day program for business startup Health Advocate X Patient Advocate Certification Board National Association of Healthcare Advocacy Work Episode #68: Being a Patient Advocate is a Real Option Episode #156: How To Start A Side Gig Or Business As A Patient Navigator  

Featuring perspectives from Dr Luis Paz-Ares and Dr Misty Dawn Shields, including the following topics: Introduction: Tail on the Curve? (0:00) First-Line Chemoimmunotherapy (10:45) Maintenance Lurbinectedin (28:42) Second-Line Treatment, Tarlatamab (45:35) Ongoing Research (53:20) CME information and select publications

In the hospital setting, neurologists may be responsible for managing common end-of-life symptoms. Comprehensive end-of-life care integrates knowledge of the biomedical aspects of disease with patients' values and preferences for care; psychosocial, cultural, and spiritual needs; and support for patients and their families. In this episode, Teshamae Monteith, MD, FAAN, speaks with Claudia Z. Chou, MD, author of the article "End-of-Life Care and Hospice" in the Continuum® December 2025 Neuropalliative Care issue. Dr. Monteith is the associate editor of Continuum® Audio and an associate professor of clinical neurology at the University of Miami Miller School of Medicine in Miami, Florida. Dr. Knox is an assistant professor of neurology and a consultant in the Division of Community Internal Medicine, Geriatrics and Palliative Care at Mayo Clinic in Rochester, Minnesota. Additional Resources Read the article: End-of-Life Care and Hospice Subscribe to Continuum®: shop.lww.com/Continuum Earn CME (available only to AAN members): continpub.com/AudioCME Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Host: @headacheMD Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about earning CME, subscribing to the journal, and exclusive access to interviews not featured on the podcast. Dr Monteith: This is Dr Teshamae Monteith. Today I'm interviewing Dr Claudia Chou about her article on end-of-life care and hospice, which is found in the December 2025 Continuum issue on neuropalliative care. Welcome to our podcast. How are you? Dr Chou: I'm doing well. Thank you for having me. This is really exciting to be here. Dr Monteith: Absolutely. So, why don't you introduce yourself to our audience? Dr Chou: Sure. My name is Claudia Chou. I am a full time hospice and palliative medicine physician at Mayo Clinic in Rochester. I'm trained in neurology, movement disorders, and hospice and palliative medicine. I'm also passionate about education, and I'm the program director for the Hospice and Palliative Medicine fellowship here. Dr Monteith: Cool. So just learning about your training, I kind of have an idea of how you got into this work, but why don't you tell me what inspired you to get into this area? Dr Chou: It was chance, actually. And really just good luck, being in the right place at the right time. I was in my residency and felt like I was missing something in my training. I was seeing these patients who were suffering strokes and had acute decline in functional status. We were seeing patients with new diagnosis of glioblastoma and knowing what that future looked like for them. And while I went into neurology because of a love of neuroscience, localizing the lesion, all of those things that we all love about neurology, I still felt like I didn't have the skill set to serve patients where they perhaps needed me the most in those difficult times where they were dealing with serious illness and functional decline. And so, the serendipitous thing was that I saw a grand rounds presentation by someone who works in neurology and palliative care for people with Parkinson's disease. And truly, it's not an exaggeration to say that by the end of that lecture, I said, I need to do palliative care, I need to rotate in this, I need to learn more. I think this is what I've been missing. And I had plans to practice both movement disorders neurology and palliative care, but I finished training in 2020… and that was not a long time ago. We can think of all the things that were going on, all the different global forces that were influencing our day-to-day decisions. And the way things worked out, staying in palliative care was really what my family and I needed. Dr Monteith: Wow, so that's really interesting. Must have been a great lecturer. Dr Chou: Yes, like one of the best.  Dr Monteith: So why don't you tell me about the objectives of your article? Dr Chou: The objectives may be to fill in some of the gaps in knowledge that may be present for the general neurologist. We learn so much in neurology training, so much about how to diagnose and treat diseases, and I think I would argue that this really is part and parcel of all we should be doing. We are the experts in these diseases, and just because we're shifting to end-of-life or transitioning to a different type of care doesn't mean that we back out of someone's care entirely or transition over to a hospice or palliative care expert. It is part of our job to be there and guide patients and their care partners through this next phase. You know, I'm not saying we all need to be hospice and palliative care experts, but we need to be able to take those first steps with patients and their care partners. And so, I think objectives are really to focus in on, what are those core pieces of knowledge for end-of-life care and understanding hospice so we can take those first steps with patients and their care partners? Dr Monteith: So, why don't you give us some of those essential points in your article? Dr Chou: Yeah. In one section of the article, I talk about common symptoms that someone might experience at the end of life and how we might manage those. These days, a lot of hospitals have order sets that talk us through those symptoms. We can check things off of a drop-down menu. And yet I think there's a little bit more nuance to that. There may be situations in which we would choose one medication over another. There may be medications that we've never really thought of in terms of symptom management before. Something that I learned in my hospice and palliative medicine fellowship was that haloperidol can be helpful for nausea. I know that's usually not one of our go-tos in neurology for any number of reasons. So, I think that extra knowledge can take us pretty far when we're managing end of life symptoms, particularly in the hospital setting. And then I think the other component is the hospice component. A lot of us may have not had experience talking about hospice, talking about what hospice can provide, and again, knowing how to take those first steps with patients. We may be referring to social work or palliative medicine to start those conversations. But again, I think this is something that's definitely learnable and something that should be part of our skill set in neurology. Dr Monteith: Great. And so, when you speak about symptom management and being more comfortable with the tools that we have, how can we be more efficient and more effective at that? Dr Chou: Think about what the common symptoms are at end of life. We may know this kind of intuitively, but what we commonly see are things like pain, nausea, dyspnea, anxiety, delirium or agitation. And so, I think having a little bit of a checklist in mind can be helpful. You know, how can I systematically think through a differential, almost, for why my patient might be uncomfortable? Why they might be restless? Have I thought through these different symptoms? Can I try a medication from my tool kit? See if that works, and if it does, we can continue on. If not, what's the next thing that I can pivot to? So, I think these are common skills for a little bit of a differential diagnosis, if you will, and how to work through these problems just with the end-of-life lens on it. Dr Monteith: So, are there any, like, validated tools or checklists that are freely available? Dr Chou: I don't think there's been anything particularly validated for end-of-life care in neurologic disease. And so, a lot of our treatments and our approaches are empiric, but I don't think there's been anything validated, per se. Dr Monteith: Great. So, why don't we talk a little bit about the approach to discussions on hospice? We all, as you kind of alluded to, want to be effective neurologists, care for our patients, but we sometimes deal with very debilitating diseases. And so, when we think that or suspect that our patient is kind of terminally ill, how do we approach that to our patients? Of course, our patients come from different backgrounds, different experiences. So, what is your approach? Dr Chou: So, when we talk about hospice and when a patient may be appropriate for hospice, we have to acknowledge that we think that they may be in the last six months of their disease. We as the neurologist are the experts in their disease and the best ones to weigh in on that prognosis. The patient and their care partners then have to accept that the type of care that hospice provides is what makes sense for them. Hospice focuses on comfort and treating a patient's comfort as the primary goal. Hospice is not as interested in treating cancer, say, to prolong life. Hospice is not as interested in life-prolonging measures and treatments that are not focused at comfort and quality of life. And so, when we have that alignment between our understanding of a patient's disease and their prognosis and the patient care partner's goal is to focus on comfort and quality of life above all else, that's when we have a patient who might be appropriate for hospice and ready to hear more about what that actually entails. Dr Monteith: And what are some, maybe, myths that neurologist healthcare professionals may have about hospice that you really want us to kind of have some clarity on? Dr Chou: That's a great question. What we often tell patients is that hospice's goal is to help patients live as well as possible in the time that they have left. Again, our primary objective is not life prolongation, but quality of life. Hospice's goal is also not to speed up or slow down the natural dying process. Sometimes we do get questions about that: can't you make this go faster or we're ready for the end. But really, we are there to help patients along the natural journey that their body is taking them on. And I think hospice care can actually be complex. In the inpatient setting, in particular in neurology, we may be seeing patients who have suffered large strokes and have perhaps only days to a few weeks of life left. But in the outpatient setting and in the home hospice setting, patients can be on hospice for many months, and so they will have new care needs, new urinary tract infections, sometimes new rashes, the need to change their insulin regimens around to avoid extremes of hyperglycemia or hypoglycemia. So, there is a lot of complexity in that care and a lot that can be wrapped up under that quality-of-life and comfort umbrella. Dr Monteith: And to get someone to hospice requires a bit of prognostication, right? Six months of prediction in terms of a terminal illness. I know there's some nuances to that. So how can you make us feel more comfortable about making the recommendations for hospice? Dr Chou: I think this is a big challenge in the field. We're normally guided by Medicare guidelines that say when a patient might be hospice-appropriate. And so, for a neurologic disease, this really only encompasses four conditions: ALS, stroke, coma, and Alzheimer's dementia. And we can think of all the other diseases that are not encompassed in those four. And so, I think we say that we paint the picture of what it means to have a prognosis of six months or less. So, from the neurologic side, that can be, what do you know about this disease and what end-stage might look like? What is the pattern of the patient's functional decline? What are they needing more help with? Are there other factors at play such as heart failure or COPD that may in and of themselves not be a qualifying diagnosis for hospice, but when it's taken together in the whole clinical picture, you have a patient who's very ill and one that you're worried may die in the next six months or less? Dr Monteith: Then you also had some nice charts on kind of disease-specific guidelines. Can you take us a little bit through that? Dr Chou: The article does contain tables about specific criteria that may qualify someone for hospice with these neurologic conditions. And they are pretty dense. I know they're a checklist of a lot of different things. And so, how we practice is by trying to refer patients to hospice based on those guidelines as much as possible and then using our own clinical judgment as well, what we have seen through taking care of patients through the years. So, again, really going back to that decline. What is making you feel uncomfortable about this patient's prognosis? What is making you feel like, gosh, this patient could be well supported by hospice, and they could have six months or less? So, all of that should go into your decision as well. And all of that should go into your discussion with the patient and their care partners. Dr Monteith: Yeah. And reading your article, what stood out was all the services that patients can receive under hospice. So, I think sometimes people think, okay, this is terminal illness, let's get to hospice for whatever reasons, but not necessarily all the lists and lists and lists of benefits of hospice. So, I don't know that everyone's aware of all those benefits. So, can you talk to us a little bit about that? Dr Chou: Yeah, I like that you brought that up because that's also something that I often say to patients and their care partners when we're talking about hospice. When the time is right for a patient to enroll in hospice, they should not feel like they're giving anything up. There should be no more clinical trial that they're hoping to chase down, and so they should just feel like they're gaining all of those good supports: care that comes to their home, a team that knows them well, someone that's available twenty-four hours a day by phone and can actually even come into the home setting if needed to help with symptom management. Hospice comes as well with the psychosocial supports for just coping with what dying looks like. We know that's not easy to be thinking about dying for oneself, or for a family member or care partner to be losing their loved one. So, all of those supports are built into hospice. I did want to make a distinction, too, that hospice does not provide custodial care, which I explain to patients as care of the body, those daily needs for bathing, dressing, eating, etc. Sometimes patients are interested in hospice because they're needing more help at home, and I have to tell them that unfortunately, our healthcare system is not built for that. And if that's the sole reason that someone is interested in hospice, we have to think about a different approach, because that is not part of the hospice benefit.  Dr Monteith: Thank you for that. And then I learned about concurrent care. So why don't you tell us a little bit about that? That's a little bit of a nuance, right? Dr Chou: Yeah, that is a little bit of a nuance. And so, typically when patients are enrolling in hospice, they are transitioning from care the way that it's normally conducted in our healthcare system. So, outpatient visits to all of the specialists and to their primary care providers, the chance to go to the ER or the ICU for higher levels of care. And yet there are a subset of patients who can still have all of those cares alongside hospice care. That really applies to two specific populations: veterans who are receiving care through the Veterans Administration, and then younger patients, so twenty six years old and less, can receive that care through, essentially, a pediatric carve out. Dr Monteith: Great. Well, I mean, you gave so much information in your article, so our listeners are going to have to read it. I don't want you to spill everything, but if you can just kind of give me a sense what you want a neurologist to take away from your article, I think that would be helpful. Dr Chou: I think what I want neurologist to take away is that, again, this is something that is part of what we do as neurologists. This is part of our skill set, and this is part of what it means to take good care of patients. I think what we do in this transition period from kind of usual cares, diagnosis, full treatment to end of life, really can have impact on patients and their care partners. It's not uncommon for me to hear from family members who have had another loved one go through hospice about how that experience was positive or negative. And so, we can think about the influence for years to come, even, because of how well we can handle these transitions. That really can be more than the patient in front of us in their journey. That is really important, but it can also have wide-reaching implications beyond that. Dr Monteith: Excellent. And I know we were talking earlier a little bit about your excitement with the field and where it's going. So why don't you share some of that excitement? Dr Chou: Yeah. And so, I think there is a lot still to come in the field of neuropalliative care, particularly from an evidence base. I know we talked a lot about the soft skills, about presence and communication, but we are clinicians at heart, and we need to practice from an evidence base. I know that's been harder in palliative care, but we have some international work groups that really are trying to come together, see what our approaches look like, see where standardization may need to happen or where our differences are actually our strength. I think there can be a lot of variability in what palliative care looks like. So, my hope is that evidence base is coming through these collaborations. I know it's hard to have a conversation these days without talking about artificial intelligence, but that is certainly a hope. When you look at morbidity, when you look at patients with these complicated disease courses, what is pointing you in the direction of, again, a prognosis of six months or less or a patient who may do better with this disease versus not? And so, I think there's a lot to come from the artificial intelligence and big data realm. For the trainees listening out there, there is no better time to be excited about neuropalliative care and to be thinking about neuropalliative care. I said that I stumbled upon this field, and hopefully someone is inspired as well by listening to these podcasts and reading Continuum to know what this field is really about. And so, it's been exponential growth since I joined this field. We have medical students now who want to come into neuropalliative care as a profession. We have clinicians who are directors of neuropalliative care at their institutions. We have an international neuropalliative care society and neuropalliative care at AAN. And I think we are moving closer to that dream for all of us, which is that patients living with serious neurologic illness can be supported throughout that journey. High-quality, evidence-based palliative care. We're not there yet, but I think it is a possibility that we reach that in my lifetime. Dr Monteith: Well, excellent. I look forward to maybe another revision of this article with some of that work incorporated. And it's been wonderful to talk to you and to reflect on how better to approach patients that are towards the end of life and to help them with that decision-making process. Thank you so much.  Dr Chou: Yeah, thank you for having me. And we're very excited about this issue. Dr Monteith: Today. I've been interviewing Dr Claudia Chou about her article on end-of-life care and hospice, which is found in the December 2025 Continuum issue on neuropalliative care. Be sure to check out Continuum Audio episodes from this and other issues, and thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. AAN members, you can get CME for listening to this interview by completing the evaluation at continpub.com/audioCME. Thank you for listening to Continuum Audio.

Pediatrician Dr. Jill Schaffeld consults Dr. Scott Pentiuk and Dr. Alex Nasr from the Division of Gastroenterology, Hepatology, and Nutrition on ingested foreign bodies. Episode recorded on July 31, 2025.  Resources discussed in this episode: Ingested Foreign Bodies - Community Practice Support Tool Financial Disclosure:  The following relevant financial relationships have been disclosed: None All relevant financial relationships listed have been mitigated. Remaining persons in control of content have no relevant financial relationships. To Claim Credit: Click "Launch Activity." Click "Launch Website" to access and listen to the podcast. After listening to the entire podcast, click "Post Test" and complete.   Accreditation In support of improving patient care, Cincinnati Children's Hospital Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Specific accreditation information will be provided for each activity. Physician:  Cincinnati Children's designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  Nursing:  This activity is approved for a maximum 0.50 continuing nursing education (CNE) contact hours. ABP MOCpt2: Completion of this CME activity, which includes learner assessment and feedback, enables the learner to earn up to 0.50 points in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. Cincinnati Children's submits MOC/CC credit for board diplomates.   Credits AMA PRA Category 1 Credits™ (0.50 hours), ABP MOC Part 2 (0.50 hours), CME - Non-Physician (Attendance) (0.50 hours), Nursing CE (0.50 hours)

Dr Luis Paz-Ares from the Spanish National Oncology Research Center in Madrid and Dr Shields from Indiana University School of Medicine in Indianapolis discuss key datasets surrounding first-line and maintenance therapy for patients with extensive-stage small cell lung cancer and their clinical implications. CME information and select publications here.

In this podcast episode, Amir T. Fathi, MD, reviews data from select presentations in leukemias at the ASH 2025 Annual Meeting, and provides perspectives on the clinical implications of these data for patients with acute myeloid leukemia (AML) or chronic myeloid leukemia (CML), including:Abstract 6: Phase II PARADIGM trial of azacitidine and venetoclax vs conventional intensive chemotherapy for fit patients with newly diagnosed AMLAbstract 47: Phase I/II SAVE trial of revumenib plus decitabine/cedazuridine and venetoclax in the cohort of patients with newly diagnosed AMLAbstract 766: Phase Ib KOMET-007 trial of ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-mutant AMLAbstract 654: Phase I/II VICEROY trial of venetoclax and azacitidine + gilteritinib in patients with newly diagnosed FLT3-mutated AML ineligible for intensive induction chemotherapyAbstract 903: 3-Yr Update of the phase II FASCINATION trial of asciminib and conventional BCR::ABL1 inhibitors in newly diagnosed CMLAbstract 906: Phase II ASC2ESCALATE trial of asciminib in patients with chronic-phase CML after 1 prior TKIPresenter:Amir T. Fathi, MDDirector, Leukemia ProgramMassachusetts General HospitalAssociate Professor of MedicineHarvard Medical SchoolBoston, MassachusettsContent based on an online CME program supported by educational grants from AstraZeneca, BeOne Medicines, Genentech, Geron Corporation, Incyte, Johnson & Johnson, Lilly, and Novartis Pharmaceuticals Corporation.Link to full program:https://bit.ly/48Ye45N Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one.—-----------------------------What if planning wasn't about rigid to-do lists… but about carving out time for surfing with your kids, date nights, and saying “no” to overwhelm?In this practical episode, Dr. Bradley Block sits with Dr. Sarah Hart-Unger to explore her simple system for goal-setting and life management. Sarah reveals how she evolved from a time-strapped resident to a mom of three who balances medicine, podcasts, and adventure. Dive into yearly visioning (e.g., “What do I really want?”), quarterly goals, monthly calendars, and daily rituals that prevent fires from derailing your dreams. She shares pitfalls like neglecting partner time, the power of friend spreadsheets, and why spontaneity thrives on structure. Drawing from her book, “Best Laid Plans“ and courses, Sarah proves planning is the “knife-sharpening” for a delicious life—efficient, fun, and regret-free.If your to-do list runs you instead of the other way around, this is your blueprint to reclaim balance and build memories that matter.Three Actionable Takeaways:Start with yearly visioning: Dedicate hours annually to brainstorm big dreams (e.g., surfing with kids). List audacious goals, then revisit seasonally. Break into quarterly milestones like booking a trip, to keep them alive. This ensures daily life aligns with what excites you, turning “someday” into reality without overwhelm.Master task management: Use a “brain dump” to capture everything, then categorize into urgent vs. important. Schedule non-negotiables first (e.g., dates, friends), block deep work, and review weekly. Embrace tools like digital calendars or spreadsheets to track progress, preventing fires while creating space for spontaneity and joy.Evaluate opportunities thoughtfully: Before saying yes, scan your calendar for fit. Consider energy, family, and fun. Phases matter: Early career? Take more risks. With kids? Be selective. Prioritize relationships (e.g., friend tiers, date nights) to avoid regrets. Planning sharpens life like a chef's knife—efficient and delicious.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest: Dr. Sarah Hart-Unger is a practicing physician, podcaster, and planning expert who honed her methods during residency and motherhood. Creator of Best Laid Plans Academy with over 100 graduates, she hosts the podcasts Best Laid Plans (solo on planning) and Best of Both Worlds (co-hosted with Laura Vanderkam on work-life fit). Her new book, Best Laid Plans: A Simple Planning System for Living a Life That You Love, offers modern tools for busy lives, balancing medicine, family, and fun.Connect with Dr. Sarah Hart-Unger:Book: Best Laid Plans (available mid-December at major retailers)Podcasts: Best Laid Plans; Best of Both WorldsWebsite: theshubox.com (for courses, blog, and more)About the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us a textImagine this: you see a patient, orders the labs, do the follow‑up, navigate the complexity, chart the visit, and deliver the care. The work is done. Then someone in the billing department closes the claim with a single click, marking it as “adjusted off.” You never see the revenue. You might not even know it was written off. That's a dollar (or many dollars) you earned but never realized—and it happens way more often than you think.Today we're going to pull back the curtain on one of the quietest, yet most destructive revenue leaks in medical group finance: adjustments—the write‑offs, the staff mistakes, the unmonitored decisions that erode your bottom line. We'll talk about what adjustments are, why many revenue cycle departments don't monitor them, the real cost of uncontrolled write‑offs, and how you can take back control. If you're a physician leader, an administrator, a CFO, or part of a practice leadership team, this episode is for you.Please Follow or Subscribe to get new episodes delivered to you as soon as they drop! Visit Jill's company, Health e Practices' website: https://healtheps.com/ Subscribe to our newsletter, Health e Connections: http://21978609.hs-sites.com/newletter-subscriber Want more formal learning? Check out Jill's newly released course: Physician's Edge: Mastering Business & Finance in Your Medical Practice. 32.5 hours of online, on-demand CME-accredited training tailored just for busy physicians. Find it here: https://healtheps.com/physicians-edge-mastering-business-finance-in-your-medical-practice/ Purchase your copy of Jill's book here: Physician Heal Thy Financial Self Join our Medical Money Matters Facebook Group here: https://www.facebook.com/groups/3834886643404507/ Original Musical Score by: Craig Addy at https://www.underthepiano.ca/ Visit Craig's website to book your Once in a Lifetime music experience Podcast coaching and development by: Jennifer Furlong, CEO, Communication Twenty-Four Seven https://www.communicationtwentyfourseven.com/

How do we hold a government accountable when we don't like the outcomes? As citizens, where do we have the greatest influence or impact on the government?In this series on healthcare and social disparities, Dr. Jill Wener, a board-certified Internal Medicine specialist, anti-racism educator, meditation expert, and tapping practitioner, interviews experts and gives her own insights into multiple fields relating to social justice and anti-racism. In this episode, Jill interviews Lindsey Cormack, PhD, an associate professor of Political Science and Director of the Diplomacy Lab at Stevens Institute of Technology. Listen for Lindsey's take on the topic of the importance of engaging in politics at a local and state level, not just the federal level. They also discussed the importance of teaching children the tools to engage in their government in an effective way.Lindsey Cormack is an associate professor of Political Science and Director of the Diplomacy Lab at Stevens Institute of Technology. She has authored two books, How to Raise a Citizen (And Why it's Up to You to Do It) and Congress and U.S. Veterans: From the GI Bill to the VA Crisis. She created and maintains the digital database of all official Congress-to-constituent e-newsletters at www.dcinbox.com. She earned her PhD in Government from New York University. She currently serves as the Secretary for Manhattan Community Board 8.LINKSwww.howtoraiseacitizen.com@howtoraiseacitizen - instagram**Our website www.consciousantiracism.comYou can learn more about Dr. Wener and her online meditation and tapping courses at www.jillwener.com, and you can learn more about her online social justice course, Conscious Anti Racism: Tools for Self-Discovery, Accountability, and Meaningful Change at https://theresttechnique.com/courses/conscious-anti-racism.If you're a healthcare worker looking for a CME-accredited course, check out Conscious Anti-Racism: Tools for Self-Discovery, Accountability, and Meaningful Change in Healthcare at www.theresttechnique.com/courses/conscious-anti-racism-healthcareJoin her Conscious Anti-Racism facebook group: www.facebook.com/groups/307196473283408Follow her on:Instagram at jillwenerMDLinkedIn at jillwenermd

In this episode of Bowel Sounds, hosts Dr. Amber Hildreth and Dr. Peter Lu talk to Dr. Tom Wallach, Assistant Professor of Pediatrics at SUNY Downstate, Chief of Pediatric Gastroenterology, Pediatric GI Fellowship director, and Research Director of Pediatrics. We talk about experience based research and how to implement these tools into medical education.Learning objectivesDefine experience based researchUnderstand how to incorporate experience based research into medical educationExplore the variety of tools available to scientists at all levels of training to conduct researchSupport the showThis episode may be eligible for CME credit! Once you have listened to the episode, click this link to claim your credit. Credit is available to NASPGHAN members (if you are not a member, you should probably sign up). And thank you to the NASPGHAN Professional Education Committee for their review!As always, the discussion, views, and recommendations in this podcast are the sole responsibility of the hosts and guests and are subject to change over time with advances in the field.Check out our merch website!Follow us on Bluesky, Twitter, Facebook and Instagram for all the latest news and upcoming episodes.Click here to support the show.

Your work world is built on endurance, intensity, and mastery. The culture is 'always on,' and you were trained to perform in conditions no one would call normal. The work is supranormal. It sits at the edge of reasonable and regularly exceeds what is sustainable by most standards. High performers like you often find themselves on an above-the-fray pedestal, expected to be tireless and self-sacrificing. Supranormal work can unlock extraordinary performance, but the cost adds up if it goes unchecked. In this episode, we look at where this culture came from, the cortisol spikes that shape your days, the hidden curriculum of self-sacrifice, and the countermeasures that keep you from burning out. It is a straight look at the supranormal experience and what it takes to do this work without losing yourself to it.Awake + Aware | Our 2026 RetreatJoin us at Awake and Aware, our 3-day retreat in Scottsdale, AZ. March 1-4, 2026. Space is limited.Learn More Here

When was Christ born? I held a livestream to tackle some of the most enduring mysteries surrounding the Christmas story, diving deep into scholarly debates concerning the timing of Christ's birth, the nature of the Star of Bethlehem, and the identity and traditions surrounding the Wise Men. The discussion also included a giveaway of a free copy of Sand Tanner’s book, Lighthouse, authored by Ronald Huggins. https://www.youtube.com/watch?v=3d0hOvJoXQc Don't miss our other conversations about Christmas: https://gospeltangents.com/lds_theology/christmas/ Copyright © 2025 Gospel Tangents All Rights Reserved The Great Dating Debate: When Was Christ Born? The discussion began by addressing the fact that the calendar we use today, created by the 6th-century monk Dionysius Exiguus. He mistakenly placed Christ's birth several years too late. There is no Year Zero. Modern scholars generally agree that Herod the Great died in 4 BC, a crucial historical marker, meaning Jesus could not have been born as late as 1 BC because Herod would have been dead for three or four years by then. Dr. Jeffrey Chadwick proposes that December of 5 BC is the correct birth month. However, Dr. Thomas Wayment argues that biblical writers like Matthew and Luke were composing gospels, not history, and were unconcerned with precise details, suggesting that historical data only allows us to know the date within a year or two, and certainly not within a specific month. Adding to the complexity is the mention of a census in Luke 2, which is historically problematic, as the census conducted by Quirinius (Cyrenius) is typically placed around 6 AD, about 10 years after Herod's death, creating a significant timeline contradiction. Explaining the Star of Bethlehem The question of what caused the Star of Bethlehem led to an examination of several astronomical and scientific theories, particularly in the context of both the Bible (Matthew 2) and the Book of Mormon (3rd Nephi 1). Information comes from several sources, including the 2004 documentary called Mystery of the Three Kings by Questar Entertainment. Planetary Alignment: Astronomer Michael Molnar proposed that the star was actually an occultation where the moon passed in front of Jupiter, a theory based on Babylon’s astrological beliefs concerning the birth dates of divine kings. Solar Eclipse: Another possibility, suggested by Jerry Grover, is a solar eclipse which occurred in 6 BC, a date near the proposed birth time. In Mesopotamia, eclipses were frequently associated with the rising of a new king or the death of an old king, which would explain why Herod was troubled. The eclipse was rare, rising in Mesoamerica and setting as a partial eclipse in Persia, where the Wise Men were thought to originate. Coronal Mass Ejection (CME): Grover also offered the idea of a CME (a massive ejection of plasma from the sun hitting Earth’s magnetosphere). This event could cause the northern lights (auroras) to become supercharged and move far south, appearing as “weird domes and other shapes in Mesoamerica”. This theory is particularly interesting because it could scientifically explain the Book of Mormon account that the night became “as light as day all night long” in the American Hemisphere, while the phenomenon might not have been noticed in the Middle East. Furthermore, the sign may have been accompanied by a crackling or hissing sound, as ions drop and release their charge in the atmosphere. Supernovas and comets are generally dismissed as options because they are either too short-lived or were historically seen as signs of impending doom. The Wise Men: Identity, Gifts, and Legacy The Wise Men (Magi or Magoi) were likely astrologers, healers, and dream readers from the east, specifically the Parthian/Persian Empire (modern Iran/Iraq area.) Their arrival in Jerusalem would have been concerning to Herod, especially since they were Persians entering Roman-controlled territory. The word Magoi is the same word used for magician or sorcerer. They may have been followers of the Zoroastrian religion, which is monotheistic and shares beliefs with Judaism, such as a belief in resurrection and a coming savior. Zoroastrian astronomers may have recognized the confluence of Jupiter and Saturn in 7 BC as a sign of a new king in Israel. The three traditional gifts carried profound meaning: Gold represented kingship. Frankincense represented divinity or God. Myrrh was extremely valuable (worth seven times the weight of gold) and represented healing; its use in embalming also served as a foreshadowing of Jesus's eventual death. The Magi are celebrated in many traditions, particularly in Spanish-speaking countries, where January 6th is known as Three Kings Day24,25. On this day, which occurs 12 days after Christmas, presents are exchanged, left by the Three Kings rather than Santa Claus. Legends regarding the Magi’s relics and tombs are found across the globe, including claims in Sava, Iran (recorded by Marco Polo); Axum, Ethiopia; Milan, Italy, and the most famous location in the West, the Cologne Cathedral in Germany. Don't miss our other conversations about Christmas: https://gospeltangents.com/lds_theology/christmas/ Copyright © 2025 Gospel Tangents All Rights Reserved

Alpha Warrior, Brad Zerbo, and Josh Reid return for another late-night After Hours session, diving into strange anomalies, missing data, and the growing conversation around solar activity and Earth's changing systems. The trio break down recent solar flares, CME activity, and irregularities in space-weather reporting, questioning why certain magnetosphere and seismic data appear delayed, altered, or quietly removed. They connect these patterns to historical solar cycles, pole-shift theories, volcanic and earthquake activity, and the broader implications for climate narratives and public preparedness. The discussion weaves through government transparency, scientific gatekeeping, and how information control shapes public perception of natural phenomena. With charts, speculation, humor, and classic After Hours tangents, Episode 9 explores whether the planet is entering a heightened phase of change, and why honest conversation about it remains so hard to find.

Welcome to the Oncology Brothers podcast! In this episode, we were joined by Dr. Rutika Mehta, a GI medical oncologist from Weill Cornell. Together, we dived into the current treatment landscape for advanced metastatic gastroesophageal junction (GEJ) and gastrointestinal carcinoma, with a special focus on HER2-positive disease. Episode Highlights: • Overview of recent advancements in the treatment of resectable disease, including the approval of Durvalumab in perioperative settings. • Discussion on the importance of biomarker testing, including HER2, PD-L1, MMR, and Claudin 18.2, in determining treatment options. • Insights into frontline treatment strategies for HER2-positive patients, including the role of trastuzumab and the addition of pembrolizumab based on PD-L1 status. • The significance of retesting HER2 expression upon disease progression and the implications for treatment decisions. • Exploration of emerging therapies like TDXd and Zanidatamab, and their potential impact on the treatment landscape. • Considerations for managing side effects and the importance of treatment sequencing in palliative care. Join us for an informative discussion that aims to keep community oncologists up to date in this ever-evolving field of cancer treatment. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more episodes covering treatment algorithms, FDA approvals, and conference highlights! Accreditation/Credit Designation Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc. Link to gain CME credits from this activity: https://www.gotoper.com/courses/biomarker-testing-in-her2-gea-diagnosis-and-treatment-implications    #HER2GastricCancer #GastricCancer #BiomarkerTesting #OncologyBrothers #GIOncology #CME

In episode 70 we discuss an article about prescription stimulant misuse. Han B, Jones CM, Volkow ND, et al.Prescription Stimulant Use, Misuse, and Use Disorder Among US Adults Aged 18 to 64 Years. JAMA Psychiatry. 2025;82(6):572–581. We also discuss the ASAM toolkit for addressing problems at the pharmacy with buprenorphine, and results of the 2024 NSDUH study. ASAM:Addressing Issues at the Pharmacy with Buprenorphine Prescriptions Link to report pharmacy issues STATNews:Tobacco use, binge drinking decrease as Americans consume more marijuana, survey finds --- This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode and others, go tothis link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visitMI CARES. CME:https://micaresed.org/courses/podcast-addiction-medicine-journal-club/ --- Original theme music:composed and performed by Benjamin Kennedy Audio editing: Michael Bonanno Executive producer:Dr. Patrick Beeman A podcast fromArs Longa Media --- This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice. The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group. --- Email: addictionmedicinejournalclub@gmail.com Facebook:@AddictionMedJC Facebook Group:Addiction Medicine Journal Club Instagram:@AddictionMedJC Threads:@AddictionMedJC YouTube:addictionmedicinejournalclub Twitter/X:@AddictionMedJC --- Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities. Learn more about your ad choices. Visit megaphone.fm/adchoices

Mindsets to avoid burnout – Julie humanizes the patient and understands that whatever difficult things we are dealing with are temporary and have gratitudeWe must constantly recognize possible anchor bias and avoid cynicism to appropriately treat our patientsWe talk about our interactions with EMSBoth Julie and I remember working in EMS and the value that EMS brings in their report because they often see a lot of things we don't get from the history of the patientJulies advice for the new APP/ER doc - don't come to premature closure on a diagnosis, don't be afraid to ask questions, pay off your loans over buying the biggest house and latest toysWe talk about the baseline level of stress we deal with We talk about technological changes over time and imaging improvementsShe talks about the challenges that the Covid pandemic presented and the shortages of different things we have now encounteredJulie still finds meaning in finding the hard differential diagnosis and working towards positive patient interactions, the teamwork in the ERI talk about the importance of creating an approachable affect so everyone feels free to voice concernsGo look at the patient when the nurse is concerned Julie talks about the benefit for new EMT's and paramedics to reach out and ask for feedback and follow up on their patients, often we don't have time to pull them asideEMS doesn't have the best mechanisms in place for good feedback on every case like we do in the ER, where we see in real time how accurate our assessment may have been when the work up comes backSupport the showEverything you hear today from myself and my guests is opinion only and doesn't represent any organizations or companies that any of us are affiliated with. The stories you hear have been modified to protect patient privacy and any resemblance to real individuals is coincidental. This is for educational and entertainment purposes only and should not be taken as medical advice nor used to diagnose any medical or healthcare conditions. This is not medical advice. If you have personal health concerns, please seek professional care. Full show notes can be found here: Episodes - Practical EMS - Content for EMTs, PAs, ParamedicsMost efficient online EKG course here: Practical EKG Interpretation - Practical EMS earn 4 CME and learn the fundamentals through advanced EKG interpretation in under 4 hours. If you want to work on your nutrition, increase your energy, improve your physical and mental health, I highly recommend 1st Phorm. Check them out here so they know I sent you. 1st Phorm | The Foundation of High Performance Nutrition

Dr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers. CME information and select publications here.

Dr Manish A Shah from Weill Cornell Medicine in New York, New York, summarizes the treatment landscape and reviews relevant clinical datasets for patients with gastroesophageal cancers. CME information and select publications here.

David Morgan is the publisher and CEO of The Morgan Report, a world-class publication designed to build and secure wealth. He talks rising prices in silver, gold, devaluation of the dollar, how they could tokenize land to back debt, CBDC, AI bubble, CME glitch, and much more. PLEASE SUBSCRIBE LIKE AND SHARE THIS PODCAST!!!    Watch Show Rumble- https://rumble.com/v72y4dc-ubi-cashless-life-and-the-boiling-frog-david-morgan.html YouTube- https://youtu.be/zgp3SME5Z0k   Follow Me X- https://x.com/CoffeeandaMike IG- https://www.instagram.com/coffeeandamike/ Facebook- https://www.facebook.com/CoffeeandaMike/ YouTube- https://www.youtube.com/@Coffeeandamike Rumble- https://rumble.com/search/all?q=coffee%20and%20a%20mike Substack- https://coffeeandamike.substack.com/ Apple Podcasts- https://podcasts.apple.com/us/podcast/coffee-and-a-mike/id1436799008 Gab- https://gab.com/CoffeeandaMike Locals- https://coffeeandamike.locals.com/ Website- www.coffeeandamike.com Email- info@coffeeandamike.com   Support My Work Venmo- https://www.venmo.com/u/coffeeandamike Paypal- https://www.paypal.com/biz/profile/Coffeeandamike Substack- https://coffeeandamike.substack.com/ Patreon- http://patreon.com/coffeeandamike Locals- https://coffeeandamike.locals.com/ Cash App- https://cash.app/$coffeeandamike Buy Me a Coffee- https://buymeacoffee.com/coffeeandamike Bitcoin- coffeeandamike@strike.me   Mail Check or Money Order- Coffee and a Mike LLC P.O. Box 25383 Scottsdale, AZ 85255-9998   Follow David X- https://x.com/silverguru22 Blog- https://www.themorganreport.com/blog/ Website-  https://www.themorganreport.com/   Sponsors Vaulted/Precious Metals- https://vaulted.blbvux.net/coffeeandamike McAlvany Precious Metals- https://mcalvany.com/coffeeandamike/ Independence Ark Natural Farming- https://www.independenceark.com/  

Dean's Chat hosts, Drs. Jensen and Richey, welcome Dr. Devon Glazer to the Podcast! This episode is sponsored by the American Podiatric Medical Association (APMA)! Dr. Devon Glazer, DPM, from Los Angeles, is a board-certified podiatric physician specializing in the medical and surgical care of foot and ankle disorders. Known for his strong fellowship program, his patient-centered approach and contemporary use of evidence-based medicine, Dr. Glazer combines precision, compassion, and innovation to help patients regain mobility and improve quality of life. Dr. Glazer completed his doctoral training in podiatric medicine followed by rigorous clinical residency training in foot and ankle surgery. He trained on the East Coast and this benefited his transition to Califonia! His clinical interests include sports injuries, trauma, reconstructive foot and ankle surgery, diabetic limb preservation, and complex forefoot and rearfoot pathology. He is recognized for his ability to translate advanced surgical techniques into practical, real-world outcomes for patients of all ages. Beyond clinical practice, Dr. Glazer is deeply committed to education, as he is the Scientific Director of "The Western", a prominant Podiatric Medical Symposium! , mentorship, and the advancement of the podiatric profession. He regularly contributes to professional development through teaching, public education, and collaborative work with peers across multidisciplinary healthcare teams. On this channel, Dr. Glazer shares: • Expert insights on foot & ankle health • Fellowship surgical education • Innovations in podiatric medicine • CME in Podiatry Whether you are a patient, student, or healthcare professional, Dr. Glazer's content is designed to educate, empower, and elevate the standard of foot and ankle care. Enjoy!

Dr Kerry A Rogers from The Ohio State University in Columbus summarizes the treatment landscape and reviews relevant clinical datasets for patients with chronic lymphocytic leukemia. CME information and select publications here.

Dr. Rob Bradsher is the Medical Director for the TeamHealth Hospitalist program at Baptist Memphis. He is from Arkansas and went to medical school at UAMS where he was inducted into Alpha Omega Alpha. He has practiced in Memphis as a hospitalist since 2014 after completing his residency training in the Osler program at Johns Hopkins Hospital. He has built a distinguished career in both academic medicine and clinical practice, serving as Program Director for a large Internal Medicine residency at the University of Tennessee Health Science Center for many years before transitioning into hospital leadership. Dr. Bradsher has been recognized with numerous teaching and leadership awards, including UTHSC's inaugural Program Director of the Year. Beyond healthcare, Dr. Bradsher is an unabashed family man, married to Allison and a proud father of 4 kids. He serves on the Board of Directors of the kids' school, Westminster Academy. He also loves tennis - as an avid recreational player, "tennis dad", and a big fan of the professional tours.With more than two decades in nursing and 16 years in leadership, Jodi Woods, MSN, RN, has dedicated her career to shaping both patient care and the growth of future leaders. Currently serving as Associate Chief Nursing Officer, she has spent 13 years at Baptist Memorial Hospital in Memphis in roles of Manager and Director, where she led teams with a focus on collaboration, innovation, and accountability. Passionate about ensuring positive patient experiences and high-quality care, Jodi thrives on mentoring and empowering others to achieve their professional goals while driving excellence in healthcare delivery.Dr. Nirmit Kothari presently serving as Associate Chief Medical Officer at Baptist Memorial Hospital, Memphis, TN. Dr. Kothari is a seasoned internist and hospital medicine specialist affiliated with Baptist Memorial Hospital–Memphis, with over two decades of medical experience.Link to claim CME credit: https://www.surveymonkey.com/r/3DXCFW3CME credit is available for up to 3 years after the stated release dateContact CEOD@bmhcc.org if you have any questions about claiming credit.

“Delivering a baby one day and holding a patient's hand at the end of life literally the next day...that continuity is very powerful,” says Dr. Jen Brull, board chair of the American Academy of Family Physicians (AAFP). And as she points out, that continuity also builds trust with patients, an increasingly valuable commodity when faith in medicine and science is declining. As you might expect given her role, Dr. Brull believes strengthening family medicine is the key to improving health and healthcare. Exactly how to do that is at the heart of her conversation with host Lindsey Smith on this episode of Raise the Line, which covers ideas for payment reform, reducing administrative burdens, and stronger support for physician well-being. And with a projected shortage of nearly forty thousand primary care physicians, Dr. Brull also shares details on AAFP's “Be There First” initiative which is designed to attract service-minded medical students – whom she describes as family physicians at heart -- early in their educational journey. “I have great hope that increasing the number of these service-first medical students will fill part of this gap.”Tune-in for an informative look at a cornerstone of the healthcare system and what it means to communities of all sizes throughout the nation.  Mentioned in this episode:AAFP If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Drs. Priya Vakharia and Sarwar Zahid join host Dr. Jay Sridhar to discuss the history, major recent changes, and future of the Good Days Chronic Disease Fund as it pertains to medical management of patients with retinal disease. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Featuring perspectives from Dr Jeremy S Abramson and Dr Loretta J Nastoupil, including the following topics: Overview of Chimeric Antigen Receptor (CAR) T-Cell Therapy (0:00) Potential Treatment Benefits of CAR T-Cell Therapy (13:31) Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome (28:13) Finding Information About CAR T-Cell Therapy; Clinical Trials (36:28) Financial Issues; Risk of Infection (42:02) Coping with Anxiety; Healing and Moving On (53:27) CME information and select publications

Dr Jeremy S Abramson from Massachusetts General Hospital in Boston and Dr Loretta J Nastoupil from CommonSpirit Mercy Hospital in Durango, Colorado, discuss the clinical applications of chimeric antigen receptor T-cell therapy for patients with non-Hodgkin lymphoma. CME information and select publications here.

Featuring an interview with Dr John V Heymach, including the following topics: Differentiating factors among various HER2 alterations in non-small cell lung cancer (NSCLC) (0:00) Activity of targeted agents across HER2 alterations in NSCLC (4:06) Available data with zongertinib and sevabertinib for HER2-mutant NSCLC (20:39) Case: A man in his late 40s with HER2-mutant NSCLC receives multiple lines of therapy, including trastuzumab deruxtecan (T-DXd) and zongertinib (29:23) Case: A woman in her mid 50s with HER2-mutant NSCLC receives zongertinib with durable response (34:23) Case: A woman in her late 50s with HER2-mutant NSCLC receives multiple lines of therapy, including sevabertinib and T-DXd (39:53) Investigational approaches in HER2-mutant NSCLC (46:31) CME information and select publications

This episode is sponsored by Lightstone DIRECT. Lightstone DIRECT invites you to partner with a $12B AUM real estate institution as you grow your portfolio. Access the same single-asset multifamily and industrial deals Lightstone pursues with its own capital – Lightstone co-invests a minimum of 20% in each deal alongside individual investors like you. You're an institution. Time to invest like one.-------------------------------------------What do you do when a colleague needs coaching but resists every step? In this essential episode for physician leaders, host Dr. Bradley Block welcomes back Dr. John Schneider, as they explore starting productive conversations with those who don't want to hear it: from remediation for below-standard behavior to subtle issues. Dr. Schneider stresses asking questions from their perspective, building psychological safety, and inviting participation to open doors for change, not pushing through them. He warns against "hammer" approaches like HR escalation unless minimum competencies fail, and shares the "challenge plus support" quadrant: challenge without support leads to retreat; support without challenge stalls growth. Drawing from his roles as Assistant Dean for Faculty Coaching and private practice coach, he emphasizes leading with belief in people, connecting to their original "calling" in medicine, and accepting that not everyone will walk through the door. If you're in leadership facing resistance. This episode offers nuanced, practical strategies to foster trust, inspire evolution, and avoid burnout for you and your team.Three Actionable Takeaways:Start with Their Perspective, Not Yours: When addressing resistance, ask questions that uncover what they need, not what you think they need. Avoid starting from remediation or "hammer" tactics; build psychological safety by showing you believe in them, inviting participation to make change feel meaningful and voluntary.Balance Challenge and Support for Growth: Use the quadrants: Challenge without support causes retreat; support without challenge leads to stagnation. As a leader, consciously provide both, holding accountable while being "with them" to open doors for self-reflection and behavior shifts, even if they don't always step through.Reconnect to Their Original Calling: Remind resistant colleagues of why they chose medicine, the inspiration that's often buried under policies and metrics. Frame changes as ways to rediscover that purpose, making evolution feel like a personal win, not an imposed fix; not everyone changes, but this invites possibility.About the Show:Succeed In Medicine  covers patient interactions, burnout, career growth, personal finance, and more. If you're tired of dull medical lectures, tune in for real-world lessons we should have learned in med school!About the Guest: Dr. John Schneider is the Division Chief of Rhinology and Anterior Skull Base Surgery and Associate Professor at Washington University in St. Louis. He serves as the university's first Assistant Dean for Faculty Coaching and is a Master Certified Physician Development Coach. In addition to his academic and clinical roles, Dr. Schneider runs his own coaching practice called Physicians' Mind Coaching, focused on helping physicians improve self-awareness, leadership, communication, and professional fulfillment. He is a nationally recognized expert in physician coaching, particularly in having difficult conversations, addressing disruptive behavior, building psychological safety, and guiding reluctant physicians toward personal and professional growth. He trains faculty coaches at Wash U and frequently speaks on topics including conflict resolution, the coach approach in leadership, and burnout prevention.Email:   john@physiciansmind.comAbout the Host:Dr. Bradley Block – Dr. Bradley Block is a board-certified otolaryngologist at ENT and Allergy Associates in Garden City, NY. He specializes in adult and pediatric ENT, with interests in sinusitis and obstructive sleep apnea. Dr. Block also hosts Succeed In Medicine podcast, focusing on personal and professional development for physiciansWant to be a guest?Email Brad at brad@physiciansguidetodoctoring.com  or visit www.physiciansguidetodoctoring.com to learn more!Socials:@physiciansguidetodoctoring on Facebook@physicianguidetodoctoring on YouTube@physiciansguide on Instagram and Twitter This medical podcast is your physician mentor to fill the gaps in your medical education. We cover physician soft skills, charting, interpersonal skills, doctor finance, doctor mental health, medical decisions, physician parenting, physician executive skills, navigating your doctor career, and medical professional development. This is critical CME for physicians, but without the credits (yet). A proud founding member of the Doctor Podcast Network!Visit www.physiciansguidetodoctoring.com to connect, dive deeper, and keep the conversation going. Let's grow! Disclaimer:This podcast is for informational purposes only and is not a substitute for professional medical, financial, or legal advice. Always consult a qualified professional for personalized guidance. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

If you're a physician with at least 5 years of experience looking for a flexible, non-clinical, part-time medical-legal consulting role… ...Dr. Armin Feldman's Medical Legal Coaching program will guarantee to add $100K in additional income within 12 months without doing any expert witness work. Any doctor in any specialty can do this work. And if you don't reach that number, he'll work with you for free until you do, guaranteed. How can he make such a bold claim? It's simple, he gets results…  Dr. David exceeded his clinical income without sacrificing time in his full-time position. Dr. Anke retired from her practice while generating the same monthly consulting income.  And Dr. Elliott added meaningful consulting work without lowering his clinical income or job satisfaction. So, if you're a physician with 5+ years of experience and you want to find out exactly how to add $100K in additional consulting income in just 12 months, go to arminfeldman.com.                                                          =============== This podcast is sponsored by the Physician Executive MBA Program at the University of Tennessee Knoxville's Haslam College of Business. Thinking about a nonclinical career path? In just one year, our physician-only MBA gives you the business and leadership skills to pivot, whether into administration, consulting, entrepreneurship, or beyond. Join a nationwide network of over 1,000 physician leaders. Learn more at nonclincicalphysicians.com/physicianmba.                                                          =============== Get the FREE GUIDE to 10 Nonclinical Careers at nonclinicalphysicians.com/freeguide. Get a list of 70 nontraditional jobs at nonclinicalphysicians.com/70jobs.                                                                                                 =============== In this presentation, I share an updated list of seven fascinating and unexpected careers that physicians are quietly thriving in, far beyond traditional clinical roles. Drawing from past podcast interviews and my own experience as a CME surveyor, I highlight examples such as founding and leading professional associations, building online coaching and course businesses, part-time consulting, working as an independent disability insurance broker, serving as a chief medical officer for a Medicare administrative contractor, launching a health advocacy practice, and advising students as an academic consultant.  For each role, I explain what the work looks like, how the physicians got started, why the positions appealed to them, and what kind of income, flexibility, and purpose they've found in these paths. If you are feeling stuck or restless in clinical practice will come away with concrete, real-world examples of careers that still use medical training but offer very different ways to earn a living and help others.  You'll find links mentioned in the episode at nonclinicalphysicians.com/unexpected-careers/

Silver is flashing every warning sign in the global financial system! 
In only the last 30 days we've seen:


Dr. Kelly Casperson engages with Dr. Abraham Morgentaler and Dr. Marianne Brandon, the dynamic duo behind the Sex Doctors podcast. They discuss the evolution of testosterone therapy, the importance of advocating for women's health, and the complexities of male sexuality. The conversation emphasizes the need for open communication in relationships, the significance of mindfulness in enhancing sexual experiences, and the importance of screening for low testosterone in men. The doctors also share insights on navigating sexual boredom and mismatched desires, while providing resources for sexual health education. Takeaways The Sex Doctors Podcast aims to provide science-based insights into sexual health. Testosterone therapy has evolved significantly, challenging previous misconceptions. Medical dogmas can hinder patient care and need to be re-evaluated. Advocacy for women's health is crucial in the context of hormone therapy. Understanding male sexuality includes recognizing the reasons behind faking orgasms. Communication is key in addressing mismatched desires in relationships. Screening for low testosterone should be considered for men over 30. Mindfulness can enhance sexual experiences and intimacy. To my fellow clinicians: listen to this podcast on ⁠⁠⁠Pinnacle for FREE to earn CME credit⁠⁠⁠ Listen to my Tedx Talk: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Why we need adult sex ed⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Take my Adult Sex Ed Master Class:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠My Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Interested in my sexual health and hormone clinic? ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Waitlist is open⁠⁠⁠⁠⁠⁠⁠⁠ Thanks to our sponsor ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Midi Women's Health⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Designed by midlife experts, delivered by experienced clinicians, covered by insurance.Midi is the first virtual care clinic made exclusively for women 40+. Evidence-based treatments. Personalized midlife care.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.joinmidi.com⁠ Learn more about your ad choices. Visit podcastchoices.com/adchoices